AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
+20.89%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$144M
AUM Growth
+$144M
(-12%)
Cap. Flow
-$42.4M
Cap. Flow
% of AUM
-29.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
2
Top Buys
| 1 |
MEI Pharma
MEIP
|
$8.6M |
Top Sells
| 1 |
IQVIA
IQV
|
$34M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$9.4M |
| 3 |
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
|
$1.36M |
Sector Composition
| 1 | Healthcare | 66.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
IQVIA
IQV
$32.4B
| $58.6M | 40.72% | 1,153,773 -669,802 | -37% | -$34M |
|
|
DRTX
2
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $40.8M | 28.35% | 3,030,175 -100,649 | -3% | -$1.36M |
|
|
CMRX
3
DELISTED
Chimerix, Inc.
CMRX
| $27.9M | 19.39% | 1,222,943 | – | – |
|
|
4
MEI Pharma
MEIP
$160M
| $8.6M | 5.98% | +770,000 | New | +$8.6M |
|
|
SRNE
5
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $8M | 5.56% | 620,700 | – | – |
|
|
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – | -137,519 | Closed | -$9.4M |
|